Source: International Congress 2018 – New pharmacological strategies in airway diseases
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Montigaud (Saint-Etienne, France), S. Perinel (Saint-Etienne, France), J. Dubus (Marseille, France), M. Suau (Saint-Etienne, France), L. Leclerc (Saint-Etienne, France), N. Prevot (Saint-Etienne, France), J. Pourchez (Saint-Etienne, France). Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies. 519

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 A human-like ex vivo preclinical model for aerosol deposition studies Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Late Breaking Abstract - A novel bronchoscopic lung volume reduction device for severe emphysema: a preclinical study in pigs Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Late Breaking Abstract - Generating iPSC derived alveolar macrophages as a novel model for respiratory research Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Late Breaking Abstract - Estimation of alveolar surface area by functional morphometry utilising a premature baboon model Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021 Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Late Breaking Abstract - Use of ultra-low dose CT does not impact structure-function relationships in early Cystic Fibrosis lung disease Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Systematic review: In vivo imaging in animal models relevant to drug-induced Interstitial lung disease (DIILD) Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Hemodynamic and respiratory assessement of an ex vivo perfused rat lung model Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Progress in modelling acute lung injury in a pre-clinical mouse model Source: Eur Respir J 2012; 39: 1062-1063 Year: 2012 Deposition and pulmonary effect of nanoparticle in whole body inhalation study and in nose only inhalation study Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Late Breaking Abstract - Effects of a new airway clearance technology in children with cystic fibrosis - A homecare randomized controlled trial Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021